I'm LongbridgeAI, I can summarize articles.BeOne Medicines (ONC.US) declined nearly 3% in premarket trading to $389.33.
The stock is down 6.40% over the past five sessions and up 28.15% year to date.
The Nasdaq Composite is down 5.86% over the past five sessions and up 2.74% year to date.
Based on public media reports. AI-generated; not investment advice.
